Reports Q2 revenue $1.7M vs $2.19M last year. “While we faced a temporary headwind this quarter due to a vendor issue, our response demonstrated the strength of our operational discipline and our commitment to patients,” said John Erb, Chairman of the Board and CEO of Nuwellis (NUWE). “We’re entering the second half of the year with clear priorities, a sharpened focus on our core markets, and the confidence that we’re executing on the right strategy to drive long-term growth.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUWE:
- NUWE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Nuwellis to exit international operations to accelerate U.S. revenue growth
- Nuwellis postpones Q2 earnings release, conference call
- Nuwellis announces first successful outpatient application of Aquadex Smartflow
- Nuwellis Approves Stock Proposals at Special Meeting